文献速递细菌感染、耐药与抗菌药物

BSAC先锋系列:医护人员与抗菌药物管理的未来——教育、创新,否则付出代价

BSAC Vanguard Series: The future of healthcare workers and antimicrobial stewardship-educate, innovate, or pay the price.
PubMed 文献 · J Antimicrob Chemother · 2022-01-01

本文讨论在全球抗菌药物耐药(AMR)和抗菌药物管理(AMS)背景下,医护人员教育和培训是实施AMS的基础,但资源投入常被低估。作者提出若干新策略以弥补教育资金不足,并主张借鉴COVID-19大流行期间对教育的大力支持;若不投资于传统与创新教育,将难以培养训练有素的医护队伍来应对AMR。

要点

  • 医护人员教育和培训是实施抗菌药物管理和有效利用卫生技术的基础。
  • 在AMR负担最重、资源最紧张的地区,医护人员教育资金常被列为低优先级。
  • 作者提出新策略弥补教育资金缺口,并主张借鉴COVID-19大流行期间的教育支持经验。

核心结论

  • 若不投资于传统和创新形式的教育,培养训练有素的医护队伍以提供高质量诊疗和改善AMR患者结局的能力将消失,并可能因此付出更高代价。

研究设计与样本

  • 本文为BSAC先锋系列评论文章,作者提出若干新策略以弥补教育资金不足,并主张从COVID-19大流行期间的教育重大发展和支持中学习。

主要发现

  • 在资助多维度的AMR和AMS应对时,专门用于支持传统教育和日益增多的创新教育(尤其是数字学习形式)发展和实施的资金不足或缺乏。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In delivering global healthcare, and in the context of antimicrobial resistance (AMR) and antimicrobial stewardship (AMS) where information and knowledge is rapidly evolving, it is universally accepted that education and training of the healthcare workforce underpins the implementation of AMS and the effective use of existing and new health care technologies, therapies and informatics. Despite this, resourcing healthcare workforce education and training is often seen as a low priority, particularly in the resource-limited settings where the burden of AMR is greatest and healthcare resources are the most stretched. Therefore, it is disappointing to observe that, when funding the multi-dimensional AMR and AMS response, specific funding earmarked to support the development and implementation of both traditional and, increasingly, innovative education (particularly in the form of digital learning) is insufficient or lacking. In this article, I propose several novel strategies for addressing this deficit and to steer us to learn from the significant developments and support for education during the COVID-19 pandemic. If we do not invest in both traditional and innovative forms of education, our ability to create a well-trained healthcare workforce to deliver high-quality care and treatment, with better patient outcomes against AMR, will evaporate-and we will likely pay a far higher price as a consequence.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Nathwani D. BSAC Vanguard Series: The future of healthcare workers and antimicrobial stewardship-educate, innovate, or pay the price. J Antimicrob Chemother. 2022. PMID: 35022733. doi:10.1093/jac/dkab484

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。